傳美國或考慮將阿里及騰訊納入禁止投資名單 阿里美股挫逾5%
《華爾街日報》引述消息人士報道,最近數周美國國務院與國防部官員討論擴大禁止美國投資中國軍方擁有或控制企業的名單,並考慮將阿里巴巴(09988.HK)(BABA.US)及騰訊(00700.HK)納入名單當中。
據悉,上述部門已經與財政部就擴大黑名單會否對資本市場產生廣泛影響進行討論,有關擴大黑名單的計劃仍在審議當中,有可能不會獲得通過。
受消息影響,阿里巴巴在美國的股價急跌5.35%,報227.61美元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.